Ferdinandos Skoulidis

Ferdinandos Skoulidis

UNVERIFIED PROFILE

Are you Ferdinandos Skoulidis?   Register this Author

Register author
Ferdinandos Skoulidis

Ferdinandos Skoulidis

Publications by authors named "Ferdinandos Skoulidis"

Are you Ferdinandos Skoulidis?   Register this Author

21Publications

889Reads

11Profile Views

Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.

Nat Rev Cancer 2019 Sep 12;19(9):495-509. Epub 2019 Aug 12.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41568-019-0179-8DOI Listing
September 2019

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer.

Clin Cancer Res 2017 Feb 7;23(3):618-622. Epub 2016 Nov 7.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2815DOI Listing
February 2017

Personalized Medicine Tackles Clinical Resistance: Alectinib in ALK-Positive Non-Small Cell Lung Cancer Progressing on First-Generation ALK Inhibitor.

Clin Cancer Res 2016 Nov 8;22(21):5177-5182. Epub 2016 Sep 8.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1415DOI Listing
November 2016

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 Oct;34(30):3638-3647

Vassiliki Papadimitrakopoulou, J. Jack Lee, Ignacio I. Wistuba, Anne S. Tsao, Frank V. Fossella, Neda Kalhor, Sanjay Gupta, Lauren Averett Byers, Julie G. Izzo, Ximing Tang, Ferdinandos Skoulidis, Don L. Gibbons, Li Shen, Caimiao Wei, Lixia Diao, S. Andrew Peng, Jing Wang, Alda L. Tam, John V. Heymach, and Waun Ki Hong, The University of Texas MD Anderson Cancer Center, Houston, TX; Scott N. Gettinger, Sarah B. Goldberg, Ja Seok Koo, and Roy S. Herbst, Yale University, New Haven, CT; Vincent A. Miller, Foundation Medicine, Cambridge, MA; Kevin R. Coombes, Ohio State University College of Medicine, Columbus, OH; and David J. Mauro and Eric H. Rubin, Merck, North Wales, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065110PMC
October 2016

Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor.

Mol Cancer Ther 2011 Apr 2;10(4):670-8. Epub 2011 Feb 2.

Department of Oncology and the Medical Research Council Cancer Cell Unit, University of Cambridge, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 0XZ, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087888PMC
April 2011

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer.

Cancer Cell 2010 Nov 4;18(5):499-509. Epub 2010 Nov 4.

Department of Oncology and the Medical Research Council Cancer Cell Unit, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2010.10.015DOI Listing
November 2010

Ma huang associated acute liver failure requiring liver transplantation.

Eur J Gastroenterol Hepatol 2005 May;17(5):581-4

Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00042737-200505000-00017DOI Listing
May 2005

Penicillium marneffei: a pathogen on our doorstep?

J R Soc Med 2004 Aug;97(8):394-6

Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://jrsm.rsmjournals.com/cgi/doi/10.1258/jrsm.97.8.394
Publisher Site
http://dx.doi.org/10.1258/jrsm.97.8.394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079563PMC
August 2004